The global oncology positron emission tomography scan market size was valued at USD 11.74 billion in 2024. The market is projected to grow from USD 12.31 billion in 2025 to USD 18.04 billion by 2032, exhibiting a CAGR of 5.6% during the forecast period. North America dominated the oncology positron emission tomography scan market with a market share of 52.55% in 2024.
The Oncology Positron Emission Tomography Scan Market is experiencing consistent growth, driven by the increasing global burden of cancer and the growing need for advanced diagnostic imaging tools. PET scans play a critical role in cancer detection, staging, and treatment monitoring, enabling physicians to make informed therapeutic decisions. Continuous technological advancements, such as the integration of PET with CT and MRI systems, along with the introduction of novel radiotracers, are enhancing the accuracy and efficiency of cancer diagnostics. Furthermore, rising awareness about early cancer detection and expanding healthcare infrastructure across developing regions are contributing to market expansion. However, challenges such as high equipment costs, limited access to radiopharmaceuticals, and skilled personnel shortages remain key barriers to widespread adoption. Overall, the Oncology Positron Emission Tomography Scan Market is poised for significant growth through 2032, supported by innovation, increasing healthcare investments, and a growing emphasis on precision oncology.
Continue reading for more details:
https://www.fortunebusinessinsights.com/oncology-positron-emission-tomography-scan-market-113540